The specificity of FBP9R/siRNA for Fas-expressing cells, coupled with successful gene-silencing and therapeutic efficacy in the rat model of MCAO, highlights the potential of this approach for targeted interventions in brain ischemia. Here, FAS is linked to brain ischemia.